MOWI Home-Based Pilot

Sponsor
Dartmouth-Hitchcock Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT03104205
Collaborator
National Institute on Aging (NIA) (NIH)
58
1
1
34
1.7

Study Details

Study Description

Brief Summary

The goal of this study is to conduct a program of pilot research aimed at developing and evaluating a technology-assisted wellness intervention for older adults with obesity.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Evaluate home-based MOWI
N/A

Detailed Description

The national epidemic of obesity is also affecting older adults, and is associated with an increased risk of disability, nursing home placement and early mortality. Conventional weight loss programs have the potential to reduce body fat, but are difficult to access for older obese adults due to transportation and mobility challenges. The overarching goal of this study is to conduct a program of pilot research aimed at developing and evaluating a technology assisted wellness intervention for older adults with obesity.

Study Timeline:
September 2018 to April 2021:

Goal: Conduct a study of improving weight and physical function in older adults with obesity at home using video-conferencing. An mHealth obesity wellness intervention (MOWI) will integrate a fitness device with a weekly individual dietician-led nutritional session, along with twice weekly physical therapist led group exercise session performed in a person's home.

Participation Duration: Three times weekly for 6 months. We shall also have participants return to the center once monthly

Study Design

Study Type:
Interventional
Actual Enrollment :
58 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
A single arm pilot interventionA single arm pilot intervention
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Mobile Health Obesity Wellness Intervention in Rural Older Adults (MOWI): Home-Based Pilot
Actual Study Start Date :
Oct 1, 2018
Actual Primary Completion Date :
Jul 1, 2020
Actual Study Completion Date :
Jul 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Evaluate home-based MOWI

Conduct and assess the feasibility, acceptability, and potential effectiveness of home-based MOWI in improving physical function.

Behavioral: Evaluate home-based MOWI
MOWI will be delivered via video-conferencing in the subject's home in a 3x per week, 26-week program from the coordinating center. It will include an individual dietician-led weekly nutrition session; 2x/week physical therapist-led group exercise session; and remote fitness device monitoring. We plan 5 cohorts of 8 subjects (n=40). In-person Research Assistant-led assessments will occur at 0, 8, 16 and 26 weeks. Recruitment, screening, selection criteria, and usability parallel Aim 2 (NCT03104192).

Outcome Measures

Primary Outcome Measures

  1. Change in Grip Strength [Change between baseline and follow-up at 26-weeks]

    Assessed by a Jamar dynamometer. Sensor-based Thera-bands will measure data on strength change.

  2. Change in 30 Second Sit-to-Stand (STS) [Change between baseline and follow-up at 26-weeks]

    STS measures lower limb strength - change represented as repetitions.

  3. Change in Six-Minute Walk Test (6MWT) [Change between baseline and follow-up at 26-weeks]

    A surrogate for cardiovascular fitness that measures distance (normal 400-700m) related to function. A clinically important difference is 50-55m

  4. Change in Gait Speed (Meters Per Second) [Change between baseline and follow-up at 26-weeks]

    Gait speed is measured by the time it takes to walk 20 meters. Gait speed predicts disability and mortality (a significant change is considered 0.1 meters per second).

  5. Change in Late-Life Function and Disability Instrument (LLFDI) [Change between baseline and follow-up at 26-weeks]

    LLFDI consists of a 32-item function and 16-item disability (life-task) scales that correlate with gait speed and lower limb function. For this instrument we use only the 32-item function and scores are scaled. Minimum 0, Maximum 100. Higher scores indicate higher levels of function

Secondary Outcome Measures

  1. Behavioral Activation (Patient Activation Measure) [Change between baseline and follow-up at 26-weeks]

    Patient Activation Measure (PAM) assesses knowledge, confidence and skill for managing health and grouped into 4 levels revealing insights into attitudes, motivators, behaviors & outcomes.

  2. Subjective Health Status (PROMIS) [Change between baseline and follow-up at 26-weeks]

    Patient Reported Outcomes Measurement Information Systems (PROMIS) Global Short Form. PROMIS is a 10-item instrument capturing physical, mental and social aspects of quality of life having undergone quantitative appraisal and is non-proprietary.

  3. Change in Weight in kg [Change between baseline and follow-up at 26-weeks]

    Change in weight in kg

  4. Change in Body Mass Index (BMI) in kg/m^2 [Change between baseline and follow-up at 26-weeks]

    Change in body mass index (BMI) in kg/m^2

  5. Change in Waist Circumference in cm [Change between baseline and follow-up at 26-weeks]

    Change in waist circumference in cm

  6. Steps [Change between baseline and follow-up at 26-weeks]

    Fitibit will assess steps

  7. Community Healthy Activities Model Program for Seniors Physical Activity Questionnaire (CHAMPS) [Change between baseline and follow-up at 26-weeks]

    CHAMPS is a self-reported tool in older adults that assesses activity levels and types

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age ≥65 years

  • Body Mass Index (BMI) ≥ 30kg/m^2 OR Waist circumference ≥88cm in females or ≥102cm in males

  • Have Wi-Fi high speed internet

  • Able to obtain medical clearance from doctor

  • Have less than a 5% weight loss in past 6 months

  • No advanced co-morbidity

  • No exercise restrictions

  • Not involved in other research studies that may interfere with participation

Exclusion Criteria:
  • Severe mental or life-threatening illness

  • Dementia

  • Substance use

  • History of bariatric surgery

  • Suicidal ideation

  • Unable to perform measures

  • Reside in nursing home

  • No advanced co-morbidity

  • No exercise restrictions

  • Not involved in other research studies that may interfere with participation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Dartmouth-Hitchcock Medical Center Lebanon New Hampshire United States 03766

Sponsors and Collaborators

  • Dartmouth-Hitchcock Medical Center
  • National Institute on Aging (NIA)

Investigators

  • Principal Investigator: John A Batsis, MD, Dartmouth-Hitchcock Medical Center / Dartmouth Medical School

Study Documents (Full-Text)

More Information

Additional Information:

Publications

None provided.
Responsible Party:
John A. Batsis, MD, Associate Professor of Medicine and of The Dartmouth Institute Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT03104205
Other Study ID Numbers:
  • D16182_3
  • K23AG051681
First Posted:
Apr 7, 2017
Last Update Posted:
Dec 20, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by John A. Batsis, MD, Associate Professor of Medicine and of The Dartmouth Institute Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title MOWI Group
Arm/Group Description Single arm study that includes the cohort. There was one arm in this study of older adults with obesity that fulfilled criteria
Period Title: Overall Study
STARTED 53
COMPLETED 44
NOT COMPLETED 9

Baseline Characteristics

Arm/Group Title Evaluate Home-based MOWI
Arm/Group Description Conduct and assess the feasibility, acceptability, and potential effectiveness of home-based MOWI in improving physical function. Evaluate home-based MOWI: MOWI will be delivered via video-conferencing in the subject's home in a 3x per week, 26-week program from the coordinating center. It will include an individual dietician-led weekly nutrition session; 2x/week physical therapist-led group exercise session; and remote fitness device monitoring. We plan 5 cohorts of 8 subjects (n=40). In-person Research Assistant-led assessments will occur at 0, 8, 16 and 26 weeks. Recruitment, screening, selection criteria, and usability parallel Aim 2 (NCT03104192).
Overall Participants 53
Age (Count of Participants)
<=18 years
0
0%
Between 18 and 65 years
0
0%
>=65 years
53
100%
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
72.9
(3.9)
Sex: Female, Male (Count of Participants)
Female
37
69.8%
Male
16
30.2%
Ethnicity (NIH/OMB) (Count of Participants)
Hispanic or Latino
0
0%
Not Hispanic or Latino
53
100%
Unknown or Not Reported
0
0%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
Asian
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
Black or African American
0
0%
White
53
100%
More than one race
0
0%
Unknown or Not Reported
0
0%
Region of Enrollment (participants) [Number]
United States
53
100%

Outcome Measures

1. Primary Outcome
Title Change in Grip Strength
Description Assessed by a Jamar dynamometer. Sensor-based Thera-bands will measure data on strength change.
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
Evaluating those completing the intervention n=33. N=11 did not complete the follow-up evaluation as a result of COVID-19 restrictions.
Arm/Group Title MOWI Group
Arm/Group Description Single arm study that includes the cohort. There was one arm in this study of older adults with obesity that fulfilled criteria
Measure Participants 33
Mean (Standard Deviation) [kg]
1.2
(7.0)
2. Primary Outcome
Title Change in 30 Second Sit-to-Stand (STS)
Description STS measures lower limb strength - change represented as repetitions.
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
Evaluating those completing the intervention n=44
Arm/Group Title MOWI Group
Arm/Group Description Single arm study that includes the cohort. There was one arm in this study of older adults with obesity that fulfilled criteria
Measure Participants 44
Mean (Standard Deviation) [repetitions]
3.1
(4.2)
3. Primary Outcome
Title Change in Six-Minute Walk Test (6MWT)
Description A surrogate for cardiovascular fitness that measures distance (normal 400-700m) related to function. A clinically important difference is 50-55m
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
Evaluating those completing the intervention n=33. N=11 did not complete the follow-up evaluation as a result of COVID-19 restrictions.
Arm/Group Title MOWI Group
Arm/Group Description Single arm study that includes the cohort. There was one arm in this study of older adults with obesity that fulfilled criteria
Measure Participants 33
Mean (Standard Deviation) [meters]
42.0
(77.3)
4. Primary Outcome
Title Change in Gait Speed (Meters Per Second)
Description Gait speed is measured by the time it takes to walk 20 meters. Gait speed predicts disability and mortality (a significant change is considered 0.1 meters per second).
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
Evaluating those completing the intervention n=33. N=11 did not complete the follow-up evaluation as a result of COVID-19 restrictions.
Arm/Group Title MOWI Group
Arm/Group Description Single arm study that includes the cohort. There was one arm in this study of older adults with obesity that fulfilled criteria
Measure Participants 33
Mean (Standard Deviation) [meters per second]
-0.34
(0.14)
5. Primary Outcome
Title Change in Late-Life Function and Disability Instrument (LLFDI)
Description LLFDI consists of a 32-item function and 16-item disability (life-task) scales that correlate with gait speed and lower limb function. For this instrument we use only the 32-item function and scores are scaled. Minimum 0, Maximum 100. Higher scores indicate higher levels of function
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
Evaluating those completing the intervention n=44
Arm/Group Title MOWI Group
Arm/Group Description Single arm study that includes the cohort. There was one arm in this study of older adults with obesity that fulfilled criteria
Measure Participants 44
Mean (Standard Deviation) [units on a scale]
3.4
(4.7)
6. Secondary Outcome
Title Behavioral Activation (Patient Activation Measure)
Description Patient Activation Measure (PAM) assesses knowledge, confidence and skill for managing health and grouped into 4 levels revealing insights into attitudes, motivators, behaviors & outcomes.
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title
Arm/Group Description
7. Secondary Outcome
Title Subjective Health Status (PROMIS)
Description Patient Reported Outcomes Measurement Information Systems (PROMIS) Global Short Form. PROMIS is a 10-item instrument capturing physical, mental and social aspects of quality of life having undergone quantitative appraisal and is non-proprietary.
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title
Arm/Group Description
8. Secondary Outcome
Title Change in Weight in kg
Description Change in weight in kg
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
Evaluating those completing the intervention n=44
Arm/Group Title MOWI Group
Arm/Group Description Single arm study that includes the cohort. There was one arm in this study of older adults with obesity that fulfilled criteria
Measure Participants 44
Mean (Standard Deviation) [kg]
-4.6
(3.5)
9. Secondary Outcome
Title Change in Body Mass Index (BMI) in kg/m^2
Description Change in body mass index (BMI) in kg/m^2
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
Evaluating those completing the intervention n=44
Arm/Group Title MOWI Group
Arm/Group Description Single arm study that includes the cohort. There was one arm in this study of older adults with obesity that fulfilled criteria
Measure Participants 44
Mean (Standard Deviation) [kg/m^2]
-1.8
(1.4)
10. Secondary Outcome
Title Change in Waist Circumference in cm
Description Change in waist circumference in cm
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
Evaluating those completing the intervention n=33. N=11 did not complete the follow-up evaluation as a result of COVID-19 restrictions.
Arm/Group Title MOWI Group
Arm/Group Description Single arm study that includes the cohort. There was one arm in this study of older adults with obesity that fulfilled criteria
Measure Participants 33
Mean (Standard Deviation) [cm]
-2.6
(5.4)
11. Secondary Outcome
Title Steps
Description Fitibit will assess steps
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
Evaluating those completing the intervention n=44
Arm/Group Title MOWI Group
Arm/Group Description Single arm study that includes the cohort. There was one arm in this study of older adults with obesity that fulfilled criteria
Measure Participants 44
Mean (Standard Deviation) [steps]
4078
(3819)
12. Secondary Outcome
Title Community Healthy Activities Model Program for Seniors Physical Activity Questionnaire (CHAMPS)
Description CHAMPS is a self-reported tool in older adults that assesses activity levels and types
Time Frame Change between baseline and follow-up at 26-weeks

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title
Arm/Group Description

Adverse Events

Time Frame 6 months - duration of the intervention
Adverse Event Reporting Description
Arm/Group Title MOWI Group
Arm/Group Description Single arm study that includes the cohort. There was one arm in this study of older adults with obesity that fulfilled criteria
All Cause Mortality
MOWI Group
Affected / at Risk (%) # Events
Total 0/53 (0%)
Serious Adverse Events
MOWI Group
Affected / at Risk (%) # Events
Total 1/53 (1.9%)
Cardiac disorders
Atrial Fibrillation 1/53 (1.9%) 1
Other (Not Including Serious) Adverse Events
MOWI Group
Affected / at Risk (%) # Events
Total 14/53 (26.4%)
Musculoskeletal and connective tissue disorders
Musculoskeletal Pain 14/53 (26.4%) 14

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title John A. Batsis
Organization Dartmouth-Hitchcock
Phone 6036505000
Email john.a.batsis@hitchcock.org
Responsible Party:
John A. Batsis, MD, Associate Professor of Medicine and of The Dartmouth Institute Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center
ClinicalTrials.gov Identifier:
NCT03104205
Other Study ID Numbers:
  • D16182_3
  • K23AG051681
First Posted:
Apr 7, 2017
Last Update Posted:
Dec 20, 2021
Last Verified:
Dec 1, 2021